Skip to main content
. 2017 Jan 31;24(4):947–951. doi: 10.1245/s10434-017-5768-8

Table 3.

Site of first recurrence

Stage Total patients Total recurrence Locoregional Systemic
Stage II 115 54 28 (52%) 26(48%)
Stage III 328 158 50 (32%) 108 (68%)
Stage IV 23 13 3 (23%) 10 (77%)
Total 466 225 81 (36%) 144 (64%)

Locoregional is defined as local, in-transit, and nodal metastases